Viewing Study NCT02415192


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-01-24 @ 9:23 PM
Study NCT ID: NCT02415192
Status: UNKNOWN
Last Update Posted: 2016-04-19
First Post: 2015-04-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
Sponsor: LG Life Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-07
Start Date Type: None
Primary Completion Date: 2016-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2016-11
Completion Date Type: ESTIMATED
First Submit Date: 2015-04-08
First Submit QC Date: None
Study First Post Date: 2015-04-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-04-18
Last Update Post Date: 2016-04-19
Last Update Post Date Type: ESTIMATED